ES2063008T3 - Nuevos (aril o heteroarilmetil)-2,2'-di-1h-imidazoles. - Google Patents

Nuevos (aril o heteroarilmetil)-2,2'-di-1h-imidazoles.

Info

Publication number
ES2063008T3
ES2063008T3 ES88111954T ES88111954T ES2063008T3 ES 2063008 T3 ES2063008 T3 ES 2063008T3 ES 88111954 T ES88111954 T ES 88111954T ES 88111954 T ES88111954 T ES 88111954T ES 2063008 T3 ES2063008 T3 ES 2063008T3
Authority
ES
Spain
Prior art keywords
heteroarilmetil
aril
imidazoles
new
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88111954T
Other languages
English (en)
Inventor
Donald P Matthews
James R Mccarthy
Jeffrey P Whitten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2063008T3 publication Critical patent/ES2063008T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ESTE INVENTO RELATA A NUEVOS (ASIL O METIL HETEROAROMATICO) -2,2''-1H-BIMIDAZOLES, A UN PROCESO PARA SU PORDUCCION QUE COMPRENDEN DE REACTIVOS UN APROPIADO ALFA-BROMINADO O ALFA-CLOVINADO, SUSTITUIDO O NO SUSTITUIDO, COMPONENTES ANULARES MONOAROMATICOS METILADOS CON 2,2''-BI-1H-INIDAZOLE EN UN SOLVENTE TAL COMO ETANO EN LA PRESENCIA DE UNA BASE COMO HIDROXIDO SODICO BAJO CONDICIONES DE REFLUJO; Y A COMPUESTOS FARMACEUTICOS Y METODOS DE TRATAR HIPERTENSIONES CON TALES COMPONENTES.
ES88111954T 1987-07-28 1988-07-25 Nuevos (aril o heteroarilmetil)-2,2'-di-1h-imidazoles. Expired - Lifetime ES2063008T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/078,352 US4839375A (en) 1987-07-28 1987-07-28 (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents

Publications (1)

Publication Number Publication Date
ES2063008T3 true ES2063008T3 (es) 1995-01-01

Family

ID=22143494

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88111954T Expired - Lifetime ES2063008T3 (es) 1987-07-28 1988-07-25 Nuevos (aril o heteroarilmetil)-2,2'-di-1h-imidazoles.

Country Status (19)

Country Link
US (1) US4839375A (es)
EP (1) EP0301456B1 (es)
JP (1) JP2750578B2 (es)
KR (1) KR970011301B1 (es)
CN (1) CN1016173B (es)
AT (1) ATE101151T1 (es)
AU (1) AU605609B2 (es)
CA (1) CA1338786C (es)
DE (1) DE3887585T2 (es)
DK (1) DK420588A (es)
ES (1) ES2063008T3 (es)
FI (1) FI883499A (es)
HU (1) HU202861B (es)
IL (1) IL87217A (es)
NO (1) NO169841C (es)
NZ (1) NZ225561A (es)
PH (1) PH26551A (es)
PT (1) PT88121B (es)
ZA (1) ZA885360B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69931837T2 (de) * 1998-03-20 2006-11-09 China Petrochemical Corp. Hydroentschwefelung von Kohlenwasserstoffölen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283661C (en) * 1984-06-20 1991-04-30 Franz Jansen Imidazolides, process for their preparation and application as intermediates for the synthesis of cytotoxic conjugates
CA1286301C (en) * 1985-11-25 1991-07-16 Donald P. Matthews 2,2'-bi-1h-imidazoles
IL82401A0 (en) * 1986-05-06 1987-11-30 Merrell Dow Pharma Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU202861B (en) 1991-04-29
KR970011301B1 (ko) 1997-07-09
DK420588A (da) 1989-01-29
FI883499A (fi) 1989-01-29
NZ225561A (en) 1990-12-21
US4839375A (en) 1989-06-13
ZA885360B (en) 1989-03-29
HUT53900A (en) 1990-12-28
DE3887585D1 (de) 1994-03-17
PH26551A (en) 1992-08-19
EP0301456A2 (en) 1989-02-01
DK420588D0 (da) 1988-07-27
NO883322D0 (no) 1988-07-27
ATE101151T1 (de) 1994-02-15
IL87217A0 (en) 1988-12-30
FI883499A0 (fi) 1988-07-25
PT88121B (pt) 1995-03-01
NO169841C (no) 1992-08-12
AU1976588A (en) 1989-02-02
KR890002112A (ko) 1989-04-08
NO169841B (no) 1992-05-04
JPS6440465A (en) 1989-02-10
EP0301456B1 (en) 1994-02-02
CN1016173B (zh) 1992-04-08
IL87217A (en) 1992-07-15
JP2750578B2 (ja) 1998-05-13
DE3887585T2 (de) 1994-05-26
CN1034718A (zh) 1989-08-16
NO883322L (no) 1989-01-30
PT88121A (pt) 1989-07-31
AU605609B2 (en) 1991-01-17
EP0301456A3 (en) 1990-12-05
CA1338786C (en) 1996-12-10

Similar Documents

Publication Publication Date Title
ES8607969A1 (es) Un procedimiento para preparar un derivado de acido quinoli-no naftiridin- carboxilico
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
ATE21105T1 (de) 7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
ATE126509T1 (de) Disäuren von diarylstyrylchinolin.
MX17846A (es) Proceso para la preparacion de nuevos derivados de 9h purina.
ES8503346A1 (es) "un procedimiento para preparar un derivado de -(4-(2-piridil)-pi-peracino)-alcanoilanilida".
ATE56211T1 (de) 2-phenylbenzoxepin-derivat.
DE69122866D1 (de) Herstellung von substituierten piperidinen
FI895185A0 (fi) Mevalonolaktoner av tienopyridintyp.
BR9105424A (pt) Processo para preparacao de um composto pesticida
ES2063008T3 (es) Nuevos (aril o heteroarilmetil)-2,2'-di-1h-imidazoles.
ES2044900T3 (es) Un proceso para la preparacion de un derivado de antraciclina.
NO904135D0 (no) Fremgangsmaate for fremstilling av nye alkylpiperidiner.
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
ES2084756T3 (es) Nuevos derivados de piridilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES535794A0 (es) Un procedimiento para preparar nuevas 5-aminometil-imidazol-1-il-1,3-dialquil-1h-pirazol-4-il-aroil-metanonas
RU93045455A (ru) Производные пиперидина, способ их получения и фармацевтическая композиция на их основе
BG95329A (bg) Метод за получаване на производни на хинолина

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301456

Country of ref document: ES